In our study; 45% of CRC cases were positive to SKP2, this matches results of Li et al., (2004), Ni et al., (2009) and Tian et al., (2013) who found that 50%, 48% and 47.6% of their studied cases respectively expressing SKP2. This evidence concerns the gene SKP2 and colorectal carcinoma.